Mark Rafferty retweeted
2900 miles in 29 days! That will definitely be fine (… she said 🙋🏻♀️)… @Beatson_Charity @POG_LRC justgiving.com/team/teamhaem…
Mark Rafferty retweeted
Coming soon …. @Beatson_Charity @POG_LRC
Mark Rafferty retweeted
Tune in to our interview w/ @graham74GC (@OUHospitals), who shares some initial results from the AVENuE window trial:
🎥 ow.ly/nCCf50OUVNg
@icmlugano #LymSM #HemOnc #Hodgkin #ImmunoOnc #17ICML
Mark Rafferty retweeted
Always a pleasure to be able to announce new research projects being funded - this one is looking at a rare type of leukaemia and has been funded thanks to the support of our #SpecialNamedFunds
Exciting #news 📣
We are proud to announce a new #ResearchProject led by @horne_gillian of @UofGlasgow that aims to improve treatment for children with a rare variant of #leukaemia.
⭐ Funded by our amazing #SNFs ⭐
More about this exciting project 👉 https://teapawt.net/t.co/4v15jWr7qF
Mark Rafferty retweeted
Great debate on the current role on CNS prophylaxis in HR DLBCL. Questions to whom and if current approaches are the correct ones are still ongoing. HR should be evaluated for occult CNS occurrence at baseline. Novel agents could have a role in prophylaxis? @mattwilson2287
Loving the RSNO John Williams concert. Baby bump was particularly wriggly in mummy’s tummy during Harry Potter & Jurassic Park scores. Showing her excellent taste in movies already #rsnofilm
7
Mark Rafferty retweeted
Since this pub just in @BloodAdvances you must listen to @AaronGoodman33 (PAPA) & @mattwilson2287 debate this exact topic on my #HealthcareUnfiltered podcast; airing on 5/4/2021.
We even pulled papa from vacation to debate this topic. Do not miss it.
ashpublications.org/bloodadv…
Mark Rafferty retweeted
The oral presentation of our UK multicentre analysis of HD-MTX CNS prophylaxis in DLBCL is now available on #EHA25Virtual. Thanks to all contributors and to the organisers.
#EHA25 #lymsm @pammckay123 @tobyeyre82 @CwynKate
Mark Rafferty retweeted
Wilson et al - multicentre retrospective study on nodular LP Hodgkin across 3 large UK centres. Med FU 8.4y. Excellent outcomes although no convincing plateau. Truly an indolent condition but not sure it’s curable as for classical #Hodgkin.
Can't wait to rock out to #Muse tonight in Glasgow! Going to be amazing! #getmeinthevault
1
























